Ezetimibe D4-O-Beta-Glucuronide
 
		Product Description
CAT No.
				
									ALN-E026D04								
				CAS No.
				
									NA								
				Mol. F.
				
									C30H25D4F2NO9								
				Mol. Wt.
				
									589.6								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : (2S,3S,4S,5R,6S)-6-(4-((2S,3R)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl-2,3,5,6-d4)-3-hydroxypropyl)-4-oxoazetidin-2-yl)phenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid								
				
									Smiles : O[C@@H](CC[C@@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(C=C3)O[C@H](O[C@@H]4C(O)=O)[C@H](O)[C@H]([C@@H]4O)O)C5=C([2H])C([2H])=C(C([2H])=C5[2H])F								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Related substances by HPLC method for the detection and evaluation of impurities in ezetimibe drug material
									By Rapeti, Durgababu; Reddy, Gudibanda Chandra Sekhar; Narayanarao, Kapavarapu Maruthi Venkata; Shyamala, Pulipaka; Krishna, Rallabhandi MuralinFrom International Journal of Pharmaceutical Sciences and Research (2021), 12(1), 217-225								
				Stability-indicating liquid chromatographic method for the simultaneous determination of rosuvastatin and ezetimibe from pharmaceuticals and biological samples
									By Kurbanoglu, Sevinc; Esim, Ozgur; Ozkan, Cansel Kose; Savaser, Ayhan; Ozkan, Yalcin; Uslu, Bengi; Ozkan, Sibel A. – From Journal of the Turkish Chemical Society, Section A: Chemistry (2020), 7(3), 865-874 								
				Stability-indicating analytical method development using quality by design approach for simultaneous estimation of ezetimibe and glimepiride
									By Shah, U.; Shah, Kunti; Patel, Rupal – From Indian Journal of Pharmaceutical Sciences (2019), 81(2), 273-281								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            